JPH0824694B2 - Contact lenses for correcting blue eyes - Google Patents

Contact lenses for correcting blue eyes

Info

Publication number
JPH0824694B2
JPH0824694B2 JP63028053A JP2805388A JPH0824694B2 JP H0824694 B2 JPH0824694 B2 JP H0824694B2 JP 63028053 A JP63028053 A JP 63028053A JP 2805388 A JP2805388 A JP 2805388A JP H0824694 B2 JPH0824694 B2 JP H0824694B2
Authority
JP
Japan
Prior art keywords
lens
ultraviolet absorber
contact lens
blue
correcting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP63028053A
Other languages
Japanese (ja)
Other versions
JPH01204668A (en
Inventor
雄一 横山
正典 大長
誠 土屋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoya Corp
Original Assignee
Hoya Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoya Corp filed Critical Hoya Corp
Priority to JP63028053A priority Critical patent/JPH0824694B2/en
Priority to CA000603575A priority patent/CA1318755C/en
Publication of JPH01204668A publication Critical patent/JPH01204668A/en
Publication of JPH0824694B2 publication Critical patent/JPH0824694B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Eyeglasses (AREA)
  • Coloring (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は青視症補正用コンタクトレンズに係り、詳し
くは白内障術後の無水晶体眼患者に生ずる青視症を補正
するためのコンタクトレンズに関する。
Description: TECHNICAL FIELD The present invention relates to a contact lens for correcting blue eyes, and more particularly to a contact lens for correcting blue eyes occurring in aphakic eye patients after cataract surgery. .

[従来の技術] 近年、老人人口の増加に伴い老人性白内障の患者人口
が増加している。白内障手術により水晶体が摘出された
無水晶体眼患者は、一般に眼鏡、コンタクトレンズ、眼
内レンズのいずれかを用い視力矯正を行なっている。
[Prior Art] In recent years, the population of patients with senile cataract has been increasing with the increase of the elderly population. An aphakic eye patient whose lens has been removed by a cataract surgery generally performs visual acuity correction using any of eyeglasses, contact lenses, and intraocular lenses.

眼鏡による矯正の場合、矯正用レンズは厚い凸レンズ
となり見た目が悪く、また、網膜像が正常眼より大きく
なる為、特に片眼無水晶体眼の場合、不等像視を生じ眼
精疲労が大きくなり使用者の負担が大きい。
In the case of correction with eyeglasses, the correction lens becomes a thick convex lens and it looks bad, and since the retinal image becomes larger than the normal eye, especially in the case of a monocular aphakic eye, unequal vision occurs and eye strain increases. The burden on the user is heavy.

そこで、近年、角膜への酸素供給性に優れ長時間装用
しても角膜への負担が少ないコンタクトレンズが開発さ
れ、無水晶体眼患者の視力矯正に非常に有効となってい
る。また、眼内に埋入することにより取りはずし不要の
眼内レンズが開発され市場に定着しつつある。視力矯正
手段として、これらコンタクトレンズや眼内レンズは前
記の眼鏡に比べ優れた点が多く今後さらに普及するもの
と予想される。
Therefore, in recent years, a contact lens that has excellent oxygen supply to the cornea and has a small burden on the cornea even when worn for a long time has been developed, and it is very effective in correcting visual acuity in aphakic patients. Further, an intraocular lens that does not need to be removed by being embedded in the eye has been developed and is becoming established in the market. These contact lenses and intraocular lenses have many advantages as the means for correcting visual acuity compared with the above-mentioned spectacles, and are expected to become more popular in the future.

ところで白内障術後の無水晶体眼患者には青視症が発
症することが知られている。青視症は、水晶体摘出眼に
発生する、白色の物体が青色に見える症状であり、水晶
体が本来黄ないし黄かつ色に着色した透光体である為、
水晶体を除去した状態では青色光(黄ないし黄かつ色の
余色)が減弱されることなく網膜に達する結果、正常眼
にくらべ物が青く見えるのである(小眼科学、改訂14
版、第28頁および第277−288頁、金原出版)。
By the way, it is known that ataxia develops in aphakic patients after cataract surgery. Blue eyesight is a symptom that occurs in the lens-extracted eye, in which a white object looks blue, and since the lens is originally a yellow or yellow and colored translucent body,
When the crystalline lens is removed, blue light (yellow or yellow and the remaining color of the color) reaches the retina without being attenuated, and as a result, the object appears blue compared to the normal eye (Ophthalmology, Rev. 14).
Edition, pages 28 and 277-288, Kanehara Publishing).

そこで、青視症の補正ができるコンタクトレンズまた
は眼内レンズが要望されており、水晶体固有の光線吸収
特性に近づける目的で、紫外線吸収剤を使用する例がみ
られ一部製品化されている。しかし、紫外線吸収剤は可
視部の吸収が極めて少なく、有害波長とされる400nm以
下の紫外線を吸収できるが、可視青色光を吸収できない
為、青視症の補正は不完全である。さらに紫外線吸収剤
を多量使用し可視領域の光線吸収を大きくしようとする
と、レンズ材料の物性低下をきたす場合が多く好ましい
ものではない。
Therefore, there is a demand for a contact lens or an intraocular lens capable of correcting blue eyesight, and an example of using an ultraviolet absorber has been seen and has been partially commercialized for the purpose of bringing it closer to the light absorption characteristics peculiar to the crystalline lens. However, the ultraviolet absorber has very little absorption in the visible region and can absorb ultraviolet rays having a harmful wavelength of 400 nm or less, but cannot absorb visible blue light, so that correction of blue eyesight is incomplete. Further, if a large amount of an ultraviolet absorber is used to increase the absorption of light in the visible region, the physical properties of the lens material are often deteriorated, which is not preferable.

他方、コンタクトレンズを着色することは従来より行
なわれて一般化しているが、従来の着色の目的は、レン
ズ使用時にレンズを見分け易くする点のみにあり、青視
症を補正するために着色剤により特定波長域の吸収を積
極的に意図する着色を施したコンタクトレンズは未だな
いのが実情である。
On the other hand, coloring of contact lenses has been conventionally performed and generalized, but the purpose of conventional coloring is only to make the lenses easily distinguishable when the lenses are used, and a coloring agent for correcting blue eyesight. Therefore, in reality, there is no contact lens that has been colored to positively intend absorption in a specific wavelength range.

[発明が解決しようとする問題点] 本発明の目的は、白内障術後の無水晶体眼に発生する
青視症を補正することができるコンタクトレンズを提供
することにある。
[Problems to be Solved by the Invention] An object of the present invention is to provide a contact lens capable of correcting blue eyesight that occurs in an aphakic eye after cataract surgery.

[問題点を解決するための手段] 本発明は上記の目的を達成するためになされたもので
あり、本発明の青視症補正用コンタクトレンズは、透明
レンズ材料に黄色ないしオレンジ色の着色剤および紫外
線吸収剤を導入することにより得られた透明着色材料か
らなることを特徴とする。
[Means for Solving the Problems] The present invention has been made to achieve the above object, and the contact lens for correcting blue eyesight according to the present invention has a transparent lens material containing a yellow or orange colorant. And a transparent coloring material obtained by introducing an ultraviolet absorber.

以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.

本発明の青視症補正用コンタクトレンズは、透明レン
ズ材料に黄色ないしオレンジ色の着色剤および紫外線吸
収剤を導入することにより得られる透明着色材料からな
るものである。
The blue-vision correcting contact lens of the present invention comprises a transparent coloring material obtained by introducing a yellow or orange coloring agent and an ultraviolet absorber into the transparent lens material.

ここに本発明の青視症補正用コンタクトレンズの母材
を構成する透明レンズ材料は透明レンズ材料として求め
られる特性を備えるものであれば特に限定されないが、
コンタクトレンズに一般に使用されているポリメチルメ
タクリレート(PMMA)が代表的なものである。これに加
え近年酸素透過性ハードコンタクトレンズに使用されて
いる含フッ素または含シリコーン(メタ)アクリレート
等の(メタ)アクリル系重合物あるいはセルローズ誘導
体、ポリスチレン、ポリカーボネート等の透明プラスチ
ック類が挙げられる。さらに、シリコーンゴム等の透明
ゴム材料も有効である。
The transparent lens material constituting the base material of the contact lens for blue-vision correction of the present invention is not particularly limited as long as it has characteristics required as a transparent lens material,
Polymethylmethacrylate (PMMA), which is commonly used for contact lenses, is typical. In addition to these, (meth) acrylic polymers such as fluorine-containing or silicone-containing (meth) acrylates which have been used for oxygen permeable hard contact lenses in recent years, or cellulose derivatives, and transparent plastics such as polystyrene and polycarbonate can be mentioned. Furthermore, transparent rubber materials such as silicone rubber are also effective.

前記透明レンズ材料への黄色ないしオレンジ色の着色
材および紫外線吸収剤の導入は、コンタクトレンズ母材
である透明材料の製造時に同時に行なわれるのが好まし
い。すなわち、コンタクトレンズ母材形成用モノマー混
合物(例えばメチルメタクリレートを主成分とし、重合
開始剤等を加えたもの)に着色剤および紫外線吸収剤を
加え、注型重合することにより、着色剤および紫外線吸
収剤が分散された着色コンタクトレンズが得られる。
It is preferable that the yellow or orange coloring material and the ultraviolet absorber are introduced into the transparent lens material at the same time when the transparent material as the contact lens base material is manufactured. That is, by adding a colorant and an ultraviolet absorber to a monomer mixture for forming a contact lens base material (for example, methylmethacrylate as a main component and adding a polymerization initiator, etc.) and casting polymerization, the colorant and the ultraviolet absorber are absorbed. A colored contact lens in which the agent is dispersed is obtained.

なお、上記注型重合法に代えて、ボタン状または棒状
重合物を得た後、これを切削研磨してコンタクトレンズ
を得る方法を採用しても良い。また重合により得られた
着色重合物をペレット化し、射出又は圧縮成形してコン
タクトレンズを得ても良い。
Instead of the cast polymerization method, a method of obtaining a contact lens by obtaining a button-shaped or rod-shaped polymer and then cutting and polishing the polymer may be adopted. Alternatively, the contact polymer may be obtained by pelletizing the colored polymer obtained by polymerization and injection or compression molding.

着色剤は本発明の青視症補正用コンタクトレンズにお
いて紫外線吸収剤とともに最も重要な物質であり、着色
剤として使用する化合物は、黄色ないしオレンジ色で、
好ましくは最大吸収波長が320nm〜450nmの間にある化合
物が適合する。
The colorant is the most important substance together with the ultraviolet absorber in the contact lens for correcting blue eyes of the present invention, and the compound used as the colorant is yellow to orange,
Compounds with a maximum absorption wavelength between 320 nm and 450 nm are preferably suitable.

着色剤の例としては、カラーインデックス(CI)に記
載されたICソルベントイエロー(Solvent Yellow)、CI
ソ ルベント オレンジ(Solvent Orange)等の油溶性
染料又はCIディスパース イエロー(Disperse Yello
w)、CIディスパース オレンジ(Disperse Ora nge)
等の分散染料が好適である。透明レンズ材料との相溶性
が良い着色剤であれば、上記以外のものでも良く、例え
ばバット系染料等を使用しても良い。特に好ましい着色
剤はCIソルベント イエロー44、CIソルベント イエロ
ー16、CIソルベント イエロー77、CIディスパース イ
エロー3等の最大吸収波長が350〜440nm付近にある化合
物である。これらの着色剤は可視光400〜500nmの吸収が
あり、なおかつ水晶体の紫外線吸収領域である300〜400
nmの光を同時に吸収できる。従って紫外、可視青色光の
吸収が可能となり、最も少ない使用量で本発明の目的を
達成し得るものである。
Examples of colorants include IC Solvent Yellow and CI listed in the Color Index (CI).
Oil-soluble dyes such as Solvent Orange or CI Disperse Yello
w), CI Disperse Orange
And the like are suitable. Any colorant other than those described above may be used as long as it has a good compatibility with the transparent lens material, and for example, a vat dye or the like may be used. Particularly preferred colorants are CI Solvent Yellow 44, CI Solvent Yellow 16, CI Solvent Yellow 77, CI Disperse Yellow 3 and other compounds having a maximum absorption wavelength in the vicinity of 350 to 440 nm. These colorants have absorption of visible light of 400 to 500 nm, and the UV absorption region of the crystalline lens is 300 to 400 nm.
It can absorb nm light at the same time. Therefore, it is possible to absorb ultraviolet light and visible blue light, and the object of the present invention can be achieved with the least amount of use.

なお、上記着色剤と同様の科学構造部分を有し、かつ
コンタクトレンズ母材形成用モノマーと共重合し得る部
分を有する着色剤も使用可能である。
It is also possible to use a colorant having the same chemical structure part as the above-mentioned colorant and having a part which can be copolymerized with the contact lens base material forming monomer.

また本発明の青視症補正用コンタクトレンズにおいて
は上述のごとき着色剤とともに紫外線吸収剤を併用する
ことを必須条件とし、これにより300nm〜450nmの波長の
光線を吸収できる。従って人水晶体の可視部吸収特性に
合わせて着色剤の種類および添加濃度を選定し、紫外部
において吸収が不足する分を紫外線吸収剤で補うことに
より一層、人水晶体の光線吸収特性に近づけることが可
能である。
In addition, in the contact lens for correcting blue eyes of the present invention, it is an essential condition to use a UV absorber together with the colorant as described above, whereby a light ray having a wavelength of 300 nm to 450 nm can be absorbed. Therefore, it is possible to further approximate the light absorption characteristics of the human crystalline lens by selecting the type and concentration of the coloring agent according to the visible absorption characteristic of the human crystalline lens and supplementing the insufficient absorption in the ultraviolet with an ultraviolet absorber. It is possible.

このような紫外線吸収剤としては、 ・ベンゾトリアゾール系 2−(2′−ヒドロキシ−5′−メチルフェニル)ベン
ゾトリアゾール[チヌビンP、チバガイギー社製)、 2−(2′−ヒドロキシ−5′−tert−ブチルフェニ
ル)ベンゾトリアゾール 2−(2′−ヒドロキシ−3′,5′−ジ−tert−ブチル
フェニル)ベンゾトリアゾール 2−(2′−ヒドロキシ−3′,5′−ジ−tert−ブチル
フェニル)−5−クロロベンゾトリアゾール 2−(2′−ヒドロキシ−3′,5′−ジ−tert−アミノ
フェニル)ベンゾトリアゾール 2−(2′−ヒドロキシ−4′−オクトキシフェニル)
ベンゾトリアゾール 2−(2′−ヒドロキシ−3′−tert−ブチル−5′−
メチルフェニル)−5−クロロベンゾトリアゾール ・サリチル酸系 フェニルサリシレート p−tert−ブチルフェニルサリシレート p−オクチルフェニルサリシレート ・ベンゾフェノン系 2,4−ジヒドロキシベンゾフェノン 2−ヒドロキシ−4−メトキシベンゾフェノン 2−ヒドロキシ−4−オクトキシベンゾフェノン 2−ヒドロキシ−4−ドデシルオキシベンゾフェノン 2,2′−ジヒドロキシ−4−メトキシベゾフェノン 2,2′−ジヒドロキシ−4,4′−ジメトキシベゾフェノン 2−ヒドロキシ−4−メトキシ−5−スルホベンゾフェ
ノン ・シアノアクリレート系 2−エチルヘキシル−2−シアノ−3,3′−ジフェニル
アクリレート エチル−2−シアノ−3,3′−ジフェニルアクリレート などが挙げられる。
Examples of such an ultraviolet absorber include: benzotriazole-based 2- (2'-hydroxy-5'-methylphenyl) benzotriazole [Tinuvin P, manufactured by Ciba Geigy], 2- (2'-hydroxy-5'-tert. -Butylphenyl) benzotriazole 2- (2'-hydroxy-3 ', 5'-di-tert-butylphenyl) benzotriazole 2- (2'-hydroxy-3', 5'-di-tert-butylphenyl) -5-chlorobenzotriazole 2- (2'-hydroxy-3 ', 5'-di-tert-aminophenyl) benzotriazole 2- (2'-hydroxy-4'-octoxyphenyl)
Benzotriazole 2- (2'-hydroxy-3'-tert-butyl-5'-
Methylphenyl) -5-chlorobenzotriazole-salicylic acid-based phenyl salicylate p-tert-butylphenyl salicylate p-octylphenyl salicylate-benzophenone-based 2,4-dihydroxybenzophenone 2-hydroxy-4-methoxybenzophenone 2-hydroxy-4-octo Xybenzophenone 2-hydroxy-4-dodecyloxybenzophenone 2,2'-dihydroxy-4-methoxybezophenone 2,2'-dihydroxy-4,4'-dimethoxybezophenone 2-hydroxy-4-methoxy-5 Sulfobenzophenone / Cyanoacrylate-based 2-Ethylhexyl-2-cyano-3,3'-diphenylacrylate Examples include ethyl-2-cyano-3,3'-diphenylacrylate.

またこれらの紫外線吸収剤と同様の化学構造部分を有
し、かつコンタクトレンズ母材形成用モノマーと共重合
し得る部分を有する反応性紫外線吸収剤も使用可能であ
る。
Further, a reactive ultraviolet absorber having a chemical structure similar to those of these ultraviolet absorbers and having a part capable of copolymerizing with the monomer for forming a contact lens base material can also be used.

従来、紫外線吸収を目的に紫外線吸収剤を使用する場
合、その使用量を0.5〜10%と多量にする必要があり、
その結果、多量の紫外線吸収剤が透明レンズ材料製造時
の重合反応を抑制し、レンズ材料の物性低下をきたす場
合があった。例えば耐溶剤性、耐熱性、硬さ等の低下の
恐れがあった。これらの諸物性はレンズ製造時に加工性
の低下にもつながる。また実際のレンズでは添加物の溶
出が生じ易くなる等安全性の面からも弊害を生じ易い これに対して本発明の青視症補正用コンタクトレンズ
では着色材の着色効果が大きい為、紫外線吸収剤単独使
用より使用量を少なくできる。従って上記弊害が少なく
なるという優れた特長も備えている。
Conventionally, when using an ultraviolet absorber for the purpose of absorbing ultraviolet rays, it is necessary to use a large amount of 0.5 to 10%,
As a result, a large amount of the ultraviolet absorber may suppress the polymerization reaction at the time of manufacturing the transparent lens material, which may deteriorate the physical properties of the lens material. For example, solvent resistance, heat resistance, hardness, etc. may be reduced. These physical properties also lead to a reduction in processability during lens production. Further, in an actual lens, adverse effects are likely to occur from the viewpoint of safety such as elution of additives easily. On the other hand, in the contact lens for correcting blue eyes disease of the present invention, the coloring effect of the coloring material is large, and therefore, the ultraviolet absorption The amount used can be less than the use of the agent alone. Therefore, it also has an excellent feature that the above adverse effects are reduced.

[実施例] 以下、実施例により本発明を更に具体的に説明する。EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples.

実施例1 メチルメタクリレート95gと、エチレングリコールジ
メタクリレート5gと、重合開始剤としてN,N′−アゾビ
スイソブチロニトリル0.1gとの混合物に、着色剤として
カラー インデックス ソルベント イエロー(CI Sol
vent Yellow)77を0.03gおよび紫外線吸収剤としてチヌ
ビンP(チバガイギー社製)を0.05g混合し溶解する。
この溶液をNo.2瀘紙で濾過した後、瀘液をパイレックス
製試験管(内径15mm)に15ml注入した後、試験管を熔封
した。この試験管を45℃の湯浴中で24時間加熱後、熱風
乾燥器中60℃で5時間、80℃で6時間加熱し室温に冷却
後、試験管を破壊し重合物を取り出した。この重合物
を、さらに熱風乾燥器中110℃で6時間加熱後、60℃ま
で6時間かけて徐冷し、さらに室温まで放冷した。
Example 1 A mixture of 95 g of methyl methacrylate, 5 g of ethylene glycol dimethacrylate, and 0.1 g of N, N′-azobisisobutyronitrile as a polymerization initiator, and a color index Solvent Yellow (CI Sol
vent Yellow) 77 and 0.05 g of Tinuvin P (manufactured by Ciba Geigy) as an ultraviolet absorber are mixed and dissolved.
After filtering this solution through No. 2 filter paper, 15 ml of the filter solution was injected into a Pyrex test tube (internal diameter 15 mm), and then the test tube was sealed. This test tube was heated in a hot water bath at 45 ° C. for 24 hours, then heated in a hot air dryer at 60 ° C. for 5 hours and at 80 ° C. for 6 hours and cooled to room temperature. Then, the test tube was broken and the polymer was taken out. The polymer was further heated in a hot air drier at 110 ° C. for 6 hours, gradually cooled to 60 ° C. over 6 hours, and then allowed to cool to room temperature.

得られた重合物から0.5mm厚のディスクを切削研磨に
て作製し、透過率曲線を測定した。これを第1図に示
す。
A disk having a thickness of 0.5 mm was prepared from the obtained polymer by cutting and polishing, and the transmittance curve was measured. This is shown in FIG.

第1図の実線aは、紫外線吸収剤併用の実施例1の重
合体の光透過率曲線、同図の破線bは紫外線吸収剤を併
用しない点でのみ実施例2の重合体と相違する重合体の
光透過率曲線であり、前者の場合、紫外線吸収が完全に
行なわれているのに対し、後者の場合、これが完全に行
なわれていないことが明らかである。
The solid line a in FIG. 1 indicates the light transmittance curve of the polymer of Example 1 which also uses an ultraviolet absorber, and the broken line b in FIG. 1 indicates the weight which differs from the polymer of Example 2 only in that no ultraviolet absorber is used. It is the light transmittance curve of the coalescence, and it is clear that in the former case, ultraviolet absorption is completely performed, whereas in the latter case, this is not completely performed.

すなわち、実施例1の結果より、可視部の光線吸収に
有効な着色剤の使用量を減少させ、可視部の色を水晶体
に近づけ、さらに300〜320nmの紫外領域を紫外線吸収剤
で吸収させることにより、300〜450nmの光線領域を吸収
させることができることが明らかとなった。
That is, from the results of Example 1, it is possible to reduce the amount of the coloring agent effective for absorbing light in the visible region, bring the color of the visible region closer to the crystalline lens, and further absorb the ultraviolet region of 300 to 320 nm with the ultraviolet absorber. Thus, it was revealed that it is possible to absorb the light region of 300 to 450 nm.

次に実施例1の重合物、紫外線吸収剤を多量に使用し
た従来の透明レンズ材料及びポリメチルメタクリレート
(PMMA)の硬度の相違を表1に示した。
Next, Table 1 shows differences in hardness between the polymer of Example 1, a conventional transparent lens material using a large amount of an ultraviolet absorber and polymethylmethacrylate (PMMA).

表−1のごとく実施例1の材料は無添加のPMMAと同等
の硬度であったが、紫外線吸収剤を多量に含む従来の材
料は硬度が低下した。従って紫外線吸収剤多量使用によ
る弊害のない本発明のコンタクトレンズの有効性が示さ
れた。
As shown in Table 1, the material of Example 1 had a hardness equivalent to that of PMMA without addition, but the hardness of the conventional material containing a large amount of the ultraviolet absorber decreased. Therefore, the effectiveness of the contact lens of the present invention, which has no adverse effect due to the use of a large amount of the ultraviolet absorber, was shown.

実施例2 着色剤としてカラー インデックス ソルベント イ
エロー(CI Solvent Yellow)77を0.02g、そして紫外線
吸収剤としてチヌビンPを0.08gを用いた以外は実施例
1と同様にして得られた棒状重合物から0.5mm厚のディ
スクを作製し光線透過率を測定した。このディスク透過
率曲線を第2図に示した。第2図の曲線aが実施例2の
重合体ディスクの透過率曲線である。また曲線bは人水
晶体の透過率曲線であり、曲線cは添加剤無添加のポリ
メチルメタクリレート(PMMA)の透過率曲線であり、曲
線d,e,f,g,h,i,j,kは従来の紫外線吸収剤含有のポリメ
チルメタクリレート製コンタクトレンズの透過率曲線で
ある。本実施例のディスクの透過率曲線は、人水晶体の
透過率曲線に極めて近似しており、他の紫外線吸収剤含
有コンタクトレンズ材料ではこのことは達成され得な
い。従って本実施例のコンタクトレンズは従来のレンズ
材料にくらべ青視症に関与する可視部の光線吸収が人水
晶体に類似しており青視症補正の有効性を裏づけるもの
であった。
Example 2 0.5 from a rod-shaped polymer obtained in the same manner as in Example 1 except that 0.02 g of CI Index Solvent Yellow 77 was used as a colorant and 0.08 g of TINUVIN P was used as an ultraviolet absorber. A mm-thick disk was prepared and the light transmittance was measured. The disc transmittance curve is shown in FIG. Curve a in FIG. 2 is the transmittance curve of the polymer disc of Example 2. Curve b is the transmittance curve of the human lens, curve c is the transmittance curve of polymethylmethacrylate (PMMA) without additives, and curves d, e, f, g, h, i, j, k FIG. 3 is a transmittance curve of a conventional polymethylmethacrylate contact lens containing an ultraviolet absorber. The transmittance curve of the disk of this example is very close to that of the human crystalline lens and this cannot be achieved with other UV absorber containing contact lens materials. Therefore, the contact lens of the present example is similar to the conventional lens material in that the light absorption in the visible region involved in blue eyesight is similar to that of the human crystalline lens, thus confirming the effectiveness of blue eye correction.

[発明の効果] 以上から明らかなごとく、本発明によれば透明レンズ
材料に黄色ないしオレンジ色の着色剤および紫外線吸収
剤を導入することにより、青視症の補正に有効なコンタ
クトレンズが得られた。
[Effects of the Invention] As is clear from the above, according to the present invention, by introducing a yellow or orange colorant and an ultraviolet absorber into a transparent lens material, a contact lens effective for correcting blue eyesight can be obtained. It was

【図面の簡単な説明】[Brief description of drawings]

第1図及び第2図は、本発明の実施例の重合物並びに比
較例及び従来例の重合物の光透過率曲線を示すグラフで
ある。
FIG. 1 and FIG. 2 are graphs showing the light transmittance curves of the polymers of Examples of the present invention and the polymers of Comparative Examples and Conventional Examples.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】透明レンズ材料に黄色ないしオレンジ色の
着色剤および紫外線吸収剤を導入することにより得られ
た透明着色材料からなることを特徴とする青視症補正用
コンタクトレンズ。
1. A contact lens for correcting blue eyes disease, which comprises a transparent coloring material obtained by introducing a yellow or orange coloring agent and an ultraviolet absorber into the transparent lens material.
JP63028053A 1988-02-09 1988-02-09 Contact lenses for correcting blue eyes Expired - Fee Related JPH0824694B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP63028053A JPH0824694B2 (en) 1988-02-09 1988-02-09 Contact lenses for correcting blue eyes
CA000603575A CA1318755C (en) 1988-02-09 1989-06-22 Process for producing cyanopsia-correctable lens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63028053A JPH0824694B2 (en) 1988-02-09 1988-02-09 Contact lenses for correcting blue eyes

Publications (2)

Publication Number Publication Date
JPH01204668A JPH01204668A (en) 1989-08-17
JPH0824694B2 true JPH0824694B2 (en) 1996-03-13

Family

ID=12238013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63028053A Expired - Fee Related JPH0824694B2 (en) 1988-02-09 1988-02-09 Contact lenses for correcting blue eyes

Country Status (2)

Country Link
JP (1) JPH0824694B2 (en)
CA (1) CA1318755C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009522076A (en) * 2006-01-10 2009-06-11 ウニベルシダッド・コンプルテンセ・デ・マドリッド Therapeutic prophylactic ophthalmic lens for pseudophakic eyes and / or neurodegenerative eyes

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007952A1 (en) * 1988-03-03 1989-09-08 Hoya Corporation Process for producing intraocular lens for correcting cyanopia
JP3953536B2 (en) * 1992-10-30 2007-08-08 株式会社ニデック Intraocular lens
JP4896737B2 (en) 2003-12-29 2012-03-14 アボット・メディカル・オプティクス・インコーポレイテッド Intraocular lens with visible light selective transmission region
AU2005242823B2 (en) 2004-04-30 2011-04-14 Johnson & Johnson Surgical Vision, Inc. Ophthalmic devices having a highly selective violet light transmissive filter and related methods
BRPI0518030A (en) 2004-11-22 2008-10-28 Advanced Medical Optics Inc copolymerizable methane and anthraquinone compounds and articles containing them
EP2261696B1 (en) 2004-11-22 2012-03-14 Abbott Medical Optics Inc. Copolymerizable azo compounds and articles containing them
ES2247946B2 (en) * 2005-04-19 2006-10-01 Universidad Complutense De Madrid THERAPEUTIC CONTACT LENS FOR PSEUDO-AFAQUIC EYES AND / OR IN NEURODEGENERATION PROCESS.
US7842367B2 (en) 2005-05-05 2010-11-30 Key Medical Technologies, Inc. Ultra violet, violet, and blue light filtering polymers for ophthalmic applications
US20120075577A1 (en) 2006-03-20 2012-03-29 Ishak Andrew W High performance selective light wavelength filtering providing improved contrast sensitivity
US9377569B2 (en) 2006-03-20 2016-06-28 High Performance Optics, Inc. Photochromic ophthalmic systems that selectively filter specific blue light wavelengths
US8113651B2 (en) 2006-03-20 2012-02-14 High Performance Optics, Inc. High performance corneal inlay
US8882267B2 (en) 2006-03-20 2014-11-11 High Performance Optics, Inc. High energy visible light filter systems with yellowness index values
CN101529311B (en) * 2006-08-23 2011-12-21 高效光学技术有限公司 System and method for selective light inhibition
US9798163B2 (en) 2013-05-05 2017-10-24 High Performance Optics, Inc. Selective wavelength filtering with reduced overall light transmission
US9683102B2 (en) 2014-05-05 2017-06-20 Frontier Scientific, Inc. Photo-stable and thermally-stable dye compounds for selective blue light filtered optic
CA3010331C (en) 2016-02-22 2021-06-22 Novartis Ag Uv-absorbing vinylic monomers and uses thereof
WO2017145022A1 (en) 2016-02-22 2017-08-31 Novartis Ag Uv/visible-absorbing vinylic monomers and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58104286A (en) * 1981-12-16 1983-06-21 ジェイエスアール株式会社 Production of colored molded product

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009522076A (en) * 2006-01-10 2009-06-11 ウニベルシダッド・コンプルテンセ・デ・マドリッド Therapeutic prophylactic ophthalmic lens for pseudophakic eyes and / or neurodegenerative eyes

Also Published As

Publication number Publication date
JPH01204668A (en) 1989-08-17
CA1318755C (en) 1993-06-08

Similar Documents

Publication Publication Date Title
JPH0824694B2 (en) Contact lenses for correcting blue eyes
US5846457A (en) Light filtering contact lens method
US5617154A (en) Light filtering contact lens
US8133274B2 (en) Photochromic intraocular lenses and methods of making the same
US4390676A (en) Ultraviolet absorbing lenses
US4304895A (en) Ultraviolet absorbing corneal contact lenses
US8079704B2 (en) Multifocal ophthalmic lens
AU757384B2 (en) UV blocking lenses and material containing benzotriazoles and benzophenones
ES2539166T3 (en) Manufacturing procedure and prescription of tinted lenses
JP2019510265A (en) Blue light blocking soft contact lens manufacturing method and soft contact lens manufactured using the same
USRE33477E (en) Ultraviolet absorbing hydrophilic corneal contact lenses
JP2008541798A (en) Ophthalmic instruments and methods
JPH0724052A (en) Soft eye-inlying lens for correcting protanopia
CN112213868B (en) Functional contact lens and method for dyeing functional contact lens
JP2794308B2 (en) Lens material for aphakic eyes
KR101123644B1 (en) Contact lens comprising titanium dioxide and preparation method thereof
KR101123643B1 (en) Contact lens comprising ultraviolet rays absorption material and preparation method thereof
JP3104417B2 (en) Optical materials
JPH119616A (en) Eye lens
JP2724012B2 (en) Manufacturing method of intraocular lens for blue vision correction
CN112679651A (en) Light-sensitive blue-light-proof optical material and application thereof
JP2724012C (en)
JPH0747114A (en) Intraocular implant

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees